High Reliability for Hypersexual Disorder Diagnostic CriteriaLast Updated: October 26, 2012. Proposed criteria for hypersexual disorder show high reliability and validity, according to results of a field trial conducted by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Work Group on Sexual and Gender Identity Disorders, published online Oct. 4 in The Journal of Sexual Medicine.
FRIDAY, Oct. 26 (HealthDay News) -- Proposed criteria for hypersexual disorder (HD) show high reliability and validity, according to results of a field trial conducted by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Work Group on Sexual and Gender Identity Disorders, published online Oct. 4 in The Journal of Sexual Medicine.
Rory C. Reid, Ph.D., from the University of California in Los Angeles, and colleagues assessed the inter-rater reliability and validity of the DSM-5 criteria among 207 patients seeking treatment for hypersexual behavior, a general psychiatric disorder, or a substance-related condition. HD and psychopathology were assessed by structured diagnostic interviews, and self-reported measures were utilized to assess the validity of the HD criteria.
The researchers found that inter-rater reliability was high and the HD criteria were stable over a two-week time period. The criteria for HD accurately reflected the presenting problem among patients, based on sensitivity and specificity indices. There was good validity for the diagnostic criteria for HD with theoretically related measures of hypersexuality, impulsivity, emotional dysregulation, and stress proneness, as well as good internal consistency. A vast array of consequences for hypersexual behavior was reported by patients assessed for HD; these consequences were significantly greater than those associated with a general psychiatric or substance-related condition.
"The HD criteria proposed by the DSM-5 Work Group on Sexual and Gender Identity Disorders appear to demonstrate high reliability and validity when applied to patients in a clinical setting among a group of raters with modest training on assessing HD," the authors write.
One author disclosed financial ties to the pharmaceutical industry.